Cargando…

Evaluation of the safety and immunogenicity in United Kingdom laboratory workers of a combined Haemophilus influenzae type b and meningococcal capsular group C conjugate vaccine

BACKGROUND: Although a combined Haemophilus influenzae type b (Hib)/meningococcal capsular group C (MenC) conjugate vaccine with a tetanus toxoid carrier protein (Hib/MenC-TT) is not licensed for use in those above 2 years of age due to lack of data on safety and efficacy, certain patient groups at...

Descripción completa

Detalles Bibliográficos
Autores principales:	Findlow, Jamie, Findlow, Helen, Frankland, Sarah, Holland, Ann, Holme, Daniel, Newton, Emma, Southern, Jo, Waight, Pauline, Kaczmarski, Ed, Miller, Elizabeth, Borrow, Ray
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4112987/ https://www.ncbi.nlm.nih.gov/pubmed/25071861 http://dx.doi.org/10.1186/1745-6673-9-26

Ejemplares similares

A review of complement sources used in serum bactericidal assays for evaluating immune responses to meningococcal ACWY conjugate vaccines
por: Findlow, Jamie, et al.
Publicado: (2019)

Invasive Meningococcal Capsular Group Y Disease, England and Wales, 2007–2009
por: Ladhani, Shamez N., et al.
Publicado: (2012)

Correlation of Group C Meningococcal Conjugate Vaccine Response with B- and T-Lymphocyte Activity
por: Wing, James B., et al.
Publicado: (2012)

Correction: Correlation of Group C Meningococcal Conjugate Vaccine Response with B- and T-Lymphocyte Activity
por: Wing, James B., et al.
Publicado: (2012)

Immunogenicity and safety of a quadrivalent meningococcal tetanus toxoid-conjugate vaccine (MenACYW-TT) in healthy toddlers: a Phase II randomized study
por: Vesikari, Timo, et al.
Publicado: (2020)

Persistence of antibodies in laboratory staff immunized with quadrivalent meningococcal polysaccharide vaccine
por: Elias, Johannes, et al.
Publicado: (2013)

Global Meningococcal Initiative: guidelines for diagnosis and confirmation of invasive meningococcal disease
por: VÁZQUEZ, J. A., et al.
Publicado: (2016)

The Distribution and ‘In Vivo’ Phase Variation Status of Haemoglobin Receptors in Invasive Meningococcal Serogroup B Disease: Genotypic and Phenotypic Analysis
por: Lucidarme, Jay, et al.
Publicado: (2013)

27. Immunologic Hyporesponsiveness with Subsequent Dosing of Meningococcal Vaccines: Re-Evaluating the Current Paradigm
por: Findlow, Jamie, et al.
Publicado: (2021)

Neisseria meningitidis Group A IgG1 and IgG2 Subclass Immune Response in African Children Aged 12–23 Months Following Meningococcal Vaccination
por: Holme, Daniel, et al.
Publicado: (2015)

Effectiveness of Meningococcal B Vaccine against Endemic Hypervirulent Neisseria meningitidis W Strain, England
por: Ladhani, Shamez N., et al.
Publicado: (2016)

Evolution of invasive meningococcal disease epidemiology in Europe, 2008 to 2017
por: Nuttens, Charles, et al.
Publicado: (2022)

Epidemiology of invasive meningococcal disease worldwide from 2010–2019: a literature review
por: Pardo de Santayana, Carmen, et al.
Publicado: (2023)

Epidemiologic Trends, Global Shifts in Meningococcal Vaccination Guidelines, and Data Supporting the Use of MenACWY-TT Vaccine: A Review
por: Presa, Jessica, et al.
Publicado: (2019)

Systematic literature review of the impact and effectiveness of monovalent meningococcal C conjugated vaccines when used in routine immunization programs
por: Tin Tin Htar, Myint, et al.
Publicado: (2020)

Review of clinical studies comparing meningococcal serogroup C immune responses induced by MenACWY-TT and monovalent serogroup C vaccines
por: Serra, Lidia, et al.
Publicado: (2021)

Factors contributing to the immunogenicity of meningococcal conjugate vaccines
por: Bröker, Michael, et al.
Publicado: (2016)

Commentary: Variant Signal Peptides of Vaccine Antigen, FHbp, Impair Processing Affecting Surface Localization and Antibody-Mediated Killing in Most Meningococcal Isolates
por: Liberator, Paul, et al.
Publicado: (2020)

Safety and immunogenicity of quadrivalent meningococcal polysaccharide vaccine (MPV ACYW135) compared with quadrivalent meningococcal conjugate vaccine (Menactra®) in Malian children
por: Sow, Samba O., et al.
Publicado: (2023)

A Mouse Immunogenicity Model for the Evaluation of Meningococcal Conjugate Vaccines
por: Arunachalam, Arun B., et al.
Publicado: (2022)

Meningococcal Seroepidemiology 1 Year After the PsA-TT Mass Immunization Campaign in Burkina Faso
por: Tall, Haoua, et al.
Publicado: (2015)

Genomic resolution of an aggressive, widespread, diverse and expanding meningococcal serogroup B, C and W lineage
por: Lucidarme, Jay, et al.
Publicado: (2015)

HPV Serology Testing Confirms High HPV Immunisation Coverage in England
por: Mesher, David, et al.
Publicado: (2016)

Serogroup C Neisseria meningitidis disease epidemiology, seroprevalence, vaccine effectiveness and waning immunity, England, 1998/99 to 2015/16
por: Findlow, Helen, et al.
Publicado: (2019)

An international invasive meningococcal disease outbreak due to a novel and rapidly expanding serogroup W strain, Scotland and Sweden, July to August 2015
por: Lucidarme, Jay, et al.
Publicado: (2016)

A Licensed Combined Haemophilus influenzae Type b-Serogroups C and Y Meningococcal Conjugate Vaccine
por: Perrett, Kirsten P., et al.
Publicado: (2013)

Kinetics of maternally-derived serogroup A, C, Y and W-specific meningococcal immunoglobulin G in Malian women and infants
por: Findlow, H., et al.
Publicado: (2019)

Invasive Pneumococcal Disease after Routine Pneumococcal Conjugate Vaccination in Children, England and Wales
por: Ladhani, Shamez N., et al.
Publicado: (2013)

Preparation, characterization, and immunogenicity of Haemophilus influenzae type b polysaccharide-protein conjugates
Publicado: (1980)

Herd Protection against Meningococcal Disease through Vaccination
por: Clark, Stephen A., et al.
Publicado: (2020)

Using the Indirect Cohort Design to Estimate the Effectiveness of the Seven Valent Pneumococcal Conjugate Vaccine in England and Wales
por: Andrews, Nick, et al.
Publicado: (2011)

Patterns of binding of aluminum-containing adjuvants to Haemophilus influenzae type b and meningococcal group C conjugate vaccines and components
por: Otto, Robert B.D., et al.
Publicado: (2015)

Immunogenicity of reduced dose priming schedules of serogroup C meningococcal conjugate vaccine followed by booster at 12 months in infants: open label randomised controlled trial
por: Pace, David, et al.
Publicado: (2015)

Immunogenicity and safety of a quadrivalent meningococcal tetanus toxoid-conjugate vaccine (MenACYW-TT) vs. a licensed quadrivalent meningococcal tetanus toxoid-conjugate vaccine in meningococcal vaccine-naïve and meningococcal C conjugate vaccine-primed toddlers: a phase III randomised study
por: van der Vliet, D., et al.
Publicado: (2021)

Emergency Meningococcal ACWY Vaccination Program for Teenagers to Control Group W Meningococcal Disease, England, 2015–2016
por: Campbell, Helen, et al.
Publicado: (2017)

Meningococcal infections among refugees and immigrants: silent threats of past, present and future
por: Dinleyici, Ener Cagri, et al.
Publicado: (2020)

Immunogenicity and Safety of Two Different Haemophilus influenzae Type b Conjugate Vaccines in Korean Infants
por: Kim, Kyung Hyo, et al.
Publicado: (2008)

Immunogenicity of Haemophilus influenzae Type b Conjugate Vaccines in Korean Infants: A Meta-analysis
por: Lee, Hyunju, et al.
Publicado: (2010)

Synthesis of Pseudooligosaccharides Related to the Capsular Phosphoglycan of Haemophilus influenzae Type a
por: Kamneva, Anastasia A., et al.
Publicado: (2023)

Invasive meningococcal disease in England: assessing disease burden through linkage of multiple national data sources
por: Ladhani, Shamez N, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_9jcical0fe30g8b0fkac9nphus